Viking Therapeutics (VKTX) Misses Q2 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)